Interleukin-37: A New Molecular Target for Host-Directed Therapy of Tuberculosis
Tiansheng Zheng,Baoxue Ge
DOI: https://doi.org/10.2217/fmb-2017-0030
2017-01-01
Future Microbiology
Abstract:Future MicrobiologyVol. 12, No. 6 EditorialInterleukin-37: a new molecular target for host-directed therapy of tuberculosisHaipeng Liu & Baoxue GeHaipeng Liu Shanghai TB Key Laboratory, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China & Baoxue Ge*Author for correspondence: E-mail Address: baoxue_ge@tongji.edu.cn Shanghai TB Key Laboratory, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University, Shanghai, ChinaPublished Online:8 May 2017https://doi.org/10.2217/fmb-2017-0030AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: host-directed therapyIL-37Mycobacterium tuberculosistuberculosisReferences1 Wallis RS, Hafner R. Advancing host-directed therapy for tuberculosis. Nat. Rev. Immunol. 15(4), 255–263 (2015).Crossref, Medline, CAS, Google Scholar2 Wallis RS, Maeurer M, Mwaba P et al. Tuberculosis – advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers. Lancet Infect. Dis. 16(4), e34–e46 (2016).Crossref, Medline, CAS, Google Scholar3 Liu H Zheng R, Wang P et al. IL-37 confers protection against mycobacterial infection involving suppressing inflammation and modulating T-cell activation. PLoS ONE 12(1), e0169922 (2017).Medline, Google Scholar4 Mulero JJ, Pace AM, Nelken ST et al. IL1HY1: a novel interleukin-1 receptor antagonist gene. Biochem. Biophys. Res. Commun. 263(3), 702–706 (1999).Crossref, Medline, CAS, Google Scholar5 Kumar S, McDonnell PC, Lehr R et al. Identification and initial characterization of four novel members of the interleukin-1 family. J. Biol. Chem. 275(14), 10308–10314 (2000).Crossref, Medline, CAS, Google Scholar6 Nold MF, Nold-Petry CA, Zepp JA et al. IL-37 is a fundamental inhibitor of innate immunity. Nat. Immunol. 11(11), 1014–1022 (2010).Crossref, Medline, CAS, Google Scholar7 Dinarello CA, Bufler P. Interleukin-37. Semin. Immunol. 25(6), 466–468 (2013).Crossref, Medline, CAS, Google Scholar8 Dinarello CA, Nold-Petry C, Nold M et al. Suppression of innate inflammation and immunity by interleukin-37. Eur. J. Immunol. 46(5), 1067–1081 (2016).Crossref, Medline, CAS, Google Scholar9 Nold-Petry CA, Lo CY, Rudloff I et al. IL-37 requires the receptors IL-18Ralpha and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction. Nat. Immunol. 16(4), 354–365 (2015).Crossref, Medline, CAS, Google Scholar10 Lunding L, Schroder A, Wegmann M. Allergic airway inflammation: unravelling the relationship between IL-37, IL-18Rα and Tir8/SIGIRR. Expert Rev. Respir. Med. 9(6), 739–750 (2015).Crossref, Medline, CAS, Google Scholar11 Bulau AM, Nold MF, Nold-Petry CA et al. Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses. Proc. Natl Acad. Sci. USA 111(7), 2650–2655 (2014).Crossref, Medline, CAS, Google Scholar12 Dorhoi A, Kaufmann SH. Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis. Semin. Immunopathol. 38(2), 153–166 (2016).Crossref, Medline, CAS, Google Scholar13 Lyadova IV, Panteleev AV. Th1 and Th17 cells in tuberculosis: protection, pathology, and biomarkers. Mediators Inflamm. 2015, 854507 (2015).Medline, Google Scholar14 Ye L, Jiang B, Deng J et al. IL-37 alleviates rheumatoid arthritis by suppressing IL-17 and IL-17-triggering cytokine production and limiting Th17 cell proliferation. J. Immunol. 194(11), 5110–5119 (2015).Crossref, Medline, CAS, Google Scholar15 Lunding L, Webering S, Vock C et al. IL-37 requires IL-18Ralpha and SIGIRR/IL-1R8 to diminish allergic airway inflammation in mice. Allergy 70(4), 366–373 (2015).Crossref, Medline, CAS, Google Scholar16 Luo Y, Cai X, Lui S et al. Suppression of antigen-specific adaptive immunity by IL-37 via induction of tolerogenic dendritic cells. Proc. Natl Acad. Sci. USA 111(42), 15178–15183 (2014).Crossref, Medline, CAS, Google Scholar17 Shuai X, Wei-min L, Tong YL et al. Expression of IL-37 contributes to the immunosuppressive property of human CD4+CD25+ regulatory T cells. Sci. Rep. 5, 14478 (2015).Crossref, Medline, CAS, Google Scholar18 Khan N, Vidyarthi A, Nadeem S, Negi S, Nair G, Agrewala JN. Alteration in the gut microbiota provokes susceptibility to tuberculosis. Front. Immunol. 7, 529 (2016).Crossref, Medline, Google Scholar19 Sham HP, Yu EY, Gulen MF et al. SIGIRR, a negative regulator of TLR/IL-1R signalling promotes Microbiota dependent resistance to colonization by enteric bacterial pathogens. PLoS Pathog. 9(8), e1003539 (2013).Crossref, Medline, CAS, Google Scholar20 Choi AM, Ryter SW, Levine B. Autophagy in human health and disease. N. Engl. J. Med. 368(7), 651–662 (2013).Crossref, Medline, CAS, Google Scholar21 Kimmey JM, Stallings CL. Bacterial pathogens versus autophagy: implications for therapeutic interventions. Trends Mol. Med. 22(12), 1060–1076 (2016).Crossref, Medline, CAS, Google Scholar22 Liang M, Habib Z, Sakamoto K, Chen X, Cao G. Mycobacteria and autophagy: many questions and few answers. Curr. Issues Mol. Biol. 21, 63–72 (2017).Medline, Google Scholar23 Munz C. Autophagy beyond intracellular MHC class II antigen presentation. Trends Immunol. 37(11), 755–763 (2016).Crossref, Medline, CAS, Google Scholar24 Abulkhir A, Samarani S, Amre D et al. A protective role of IL-37 in cancer: a new hope for cancer patients. J. Leukoc. Biol. 101(2), 395–406 (2017).Crossref, Medline, CAS, Google Scholar25 Agarwal P, Pandey P, Sarkar J, Krishnan MY. Mycobacterium tuberculosis can gain access to adipose depots of mice infected via the intra-nasal route and to lungs of mice with an infected subcutaneous fat implant. Microb. Pathog. 93, 32–37 (2016).Crossref, Medline, Google Scholar26 Pavan Kumar N, Nair D, Banurekha VV et al. Type 2 diabetes mellitus coincident with pulmonary or latent tuberculosis results in modulation of adipocytokines. Cytokine 79, 74–81 (2016).Crossref, Medline, CAS, Google Scholar27 Ballak DB, van Diepen JA, Moschen AR et al. IL-37 protects against obesity-induced inflammation and insulin resistance. Nat. Commun. 5, 4711 (2014).Crossref, Medline, CAS, Google Scholar28 Restrepo BI. Metformin: candidate host-directed therapy for tuberculosis in diabetes and non-diabetes patients. Tuberculosis (Edinb.) 101, S69–S72 (2016).Crossref, CAS, Google Scholar29 Oehlers SH, Cronan MR, Scott NR et al. Interception of host angiogenic signalling limits mycobacterial growth. Nature 517(7536), 612–615 (2015).Crossref, Medline, CAS, Google Scholar30 Yang T, Lin Q, Zhao M et al. IL-37 is a novel proangiogenic factor of developmental and pathological angiogenesis. Arterioscler. Thromb. Vasc. Biol. 35(12), 2638–2646 (2015).Crossref, Medline, CAS, Google Scholar31 Giovagnoli S, Schoubben A, Ricci M. The long and winding road to inhaled TB therapy: not only the bug's fault. Drug Dev. Ind. Pharm. 43(3), 347–363 (2017).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetails Vol. 12, No. 6 Follow us on social media for the latest updates Metrics Downloaded 174 times History Published online 8 May 2017 Published in print May 2017 Information© Future Medicine LtdKeywordshost-directed therapyIL-37 Mycobacterium tuberculosis tuberculosisFinancial & competing interests disclosureWork in the authors' lab was supported by grants from the National Natural Science Foundation of China (81200003, 81370108, 81330069, 91542111). H Liu is sponsored by Shanghai Pujiang Program (16PJ1408600). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.No writing assistance was utilized in the production of this manuscript.PDF download